Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study
详细信息 查看全文
- 作者：Jeffrey H. Newcorn ; Valerie Harpin ; Michael Huss ; Andrew Lyne ; Vanja Sikirica ; Mats Johnson ; Josep Antoni Ramos-Quiroga ; Judy van Stralen ; Benoit Dutray ; Sasha Sreckovic ; Ralph Bloomfield and Brigitte Robertson
- 刊名：Journal of Child Psychology and Psychiatry
- 出版年：2016
- 出版时间：June 2016
- 年：2016
- 卷：57
- 期：6
- 页码：717-728
- 全文大小：288K
- ISSN：1469-7610
文摘
Extended-release guanfacine hydrochloride (GXR), a selective α2A-adrenergic agonist, is a nonstimulant medication for attention-deficit/hyperactivity disorder (ADHD). This phase 3, double-blind, placebo-controlled, randomised-withdrawal study evaluated the long-term maintenance of GXR efficacy in children/adolescents with ADHD.